Versant Capital Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.33K Sell
86
-42
-33% -$3.02K ﹤0.01% 2334
2026
Q1
$8.44K Buy
128
+86
+205% +$5.47K ﹤0.01% 2210
2025
Q4
$2.67K Buy
+42
New +$2.61K ﹤0.01% 2400
2025
Q1
Sell
-11
Closed -$517 2546
2024
Q4
$517 Buy
+11
New +$571 ﹤0.01% 2269
2021
Q2
Sell
-419
Closed -$10K 1471
2021
Q1
$10K Sell
419
-205
-33% -$4.38K ﹤0.01% 783
2020
Q4
$12K Sell
624
-39
-6% -$713 ﹤0.01% 671
2020
Q3
$14K Hold
663
0.01% 535
2020
Q2
$15K Buy
663
+314
+90% +$5.89K 0.01% 498
2020
Q1
$4K Buy
349
+12
+4% +$153 ﹤0.01% 823
2019
Q4
$3K Hold
337
﹤0.01% 1055
2019
Q3
$3K Hold
337
﹤0.01% 1078
2019
Q2
$3K Buy
337
+256
+316% +$2.47K ﹤0.01% 1084
2019
Q1
$0 Hold
81
﹤0.01% 1588
2018
Q4
$0 Hold
81
﹤0.01% 1499
2018
Q3
$0 Buy
+81
New +$650 ﹤0.01% 1538
2018
Q2
Sell
-21
Closed 1529
2018
Q1
$0 Buy
+21
New +$180 ﹤0.01% 1512

Other funds holding CYTK